Article info
PDFPostScript
Letter
Concomitant drug use of nirmatrelvir/ritonavir and CYP3A4-modulating antimicrobial agents: an approach for drug use
- Correspondence to Nadir Yalçın, Department of Clinical Pharmacy, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey; nadir.yalcin{at}hotmail.com
Citation
Concomitant drug use of nirmatrelvir/ritonavir and CYP3A4-modulating antimicrobial agents: an approach for drug use
Publication history
- First published April 27, 2023.
Online issue publication
February 22, 2024
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists 2024. No commercial re-use. See rights and permissions. Published by BMJ.